CGAR
  • Upload sample(current)
  • Report
  • User guide
  • Version info
  • Sign in

    Parental samples for de novo candidates (Optional, e.g. Trio1 caucasian, Trio2 Han Chinese, Trio3 Ashkenazim)

    Paternal sample:

    Maternal sample:

    Phenotype(s) required for Phenotype associated tab (Optional, powered by FindZebra)
    Select top % genes.
    Gene(s) required for Focused report (Optional, E.g. here to load CENSUS genes)
    Germline sample for Cancer tab (Optional, e.g. Uveal melanoma)
    Allele frequency based on:
    Maximum across population
    Ethnicity specific: Genotype predicted
    Ethnicity specific: Self-reported


© 2017-2019 Boston Children's Hospital. Academic research use only. Disclaimer.

All Rights Reserved. NOTE: CGAR is best viewed from Google Chrome, Mozilla Firefox, or Apple Safari. Some of the features may not work properly in Microsoft Internet Explorer.

Disclaimer

The Clinical Genome & Ancestry Report (CGAR) was developed by the Children's Medical Center Corporation (CMCC), doing business as Boston Children's Hospital (BCH) and is to be used for academic research only. The CGAR is not to be used in clinical practice.

CMCC AND ITS AFFILIATES, AND THEIR RESPECTIVE PERSONNEL, MAKE NO WARRANTY, EXPRESS OR IMPLIED, INCLUDING, WITHOUT LIMITATION, ANY EXPRESS OR IMPLIED WARRANTY OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR WARRANTY OF NON-INFRINGEMENT AS TO ANY MATTER RELATING TO USE OF THE CGAR, INCLUDING WITHOUT LIMITATION ANY WARRANTY WITH RESPECT TO TECHNICAL INFORMATION, OR ANY SOFTWARE, INFORMATION OR DATA PROVIDED HEREUNDER. CMCC, its Affiliates, and their respective personnel, make no warranty, express or implied, that any use of the CGAR will not infringe any intellectual property or other property rights of CMCC, BCH, or any Third Party.

IN NO EVENT WILL CMCC, ITS AFFILIATES, OR THEIR RESPECTIVE TRUSTEES, OFFICERS, FACULTY MEMBERS, STUDENTS, STAFF, EMPLOYEES AND AGENTS, BE LIABLE TO ANY USER ANY OF THE CGAR, OR ANY THIRD PARTY, FOR ANY CONSEQUENTIAL, INCIDENTAL, SPECIAL OR INDIRECT DAMAGES (INCLUDING, BUT NOT LIMITED TO, FROM ANY DESTRUCTION TO PROPERTY OR FROM ANY LOSS OF USE, REVENUE, PROFIT, TIME OR GOOD WILL) BASED ON, ARISING OUT OF, OR RELATED TO THE USE OF THE CGAR.